(c) 2024 PillSync.com

oxycodone hydrochloride tablet

1 INDICATIONS AND USAGE Oxycodone Hydrochloride Tablets, USP are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Oxycodone hydrochloride tablets are an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. ( 1 ) Limitations of Use: Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration, reserve oxycodone hydrochloride tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or non-opioid combination products): Have not been tolerated or are not expected to be tolerated, Have not provided adequate analgesia or are not expected to provide adequate analgesia. Oxycodone hydrochloride tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see Warnings and Precautions (5.1) ], reserve Oxycodone Hydrochloride Tablets, USP for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): Have not been tolerated or are not expected to be tolerated, Have not provided adequate analgesia or are not expected to provide adequate analgesia. Oxycodone hydrochloride tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.

Rhodes Pharmaceuticals L.P.


3 years ago ROUND WHITE R P 30 oxycodone hydrochloride tablet

ROUND WHITE R P 30

3 years ago ROUND WHITE R P 30 oxycodone hydrochloride tablet

R P 30 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING

OXYCODONE HYDROCHLORIDE Tablets, USP are available as follows: 5 mg – white to off-white, round, flat faced, beveled edged tablets debossed with "R" above bisect and "P" below on one side and "5" on the other side NDC 42858-001-01: Bottles of 100 tablets NDC 42858-001-10: Unit Dose Packages of 100, 10 per Card, 10 cards per shipper 10 mg – white to off-white, round, biconvex tablets debossed with "R" above bisect and "P" below on one side and "10" on the other side NDC 42858-002-01 Bottles of 100 tablets NDC 42858-002-10: Unit Dose Packages of 100, 10 per Card, 10 cards per shipper 15 mg – white to off-white, oval tablets with "R" and "P" (with a center score) on one side and "15" on the other side NDC 42858-003-01: Bottles of 100 tablets 20 mg – white to off-white, round, biconvex tablets debossed with "R" above bisect and "P" below on one side and "20" on the other side NDC 42858-004-01: Bottles of 100 tablets 30 mg – white to off-white, round, biconvex tablets debossed with "R" above bisect and "P" below on one side and "30" on the other side NDC 42858-005-01: Bottles of 100 tablets Dispense in a tight, light-resistant container. Protect from moisture. Store at 25°C (77°F); excursions are permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Store

OXYCODONE HYDROCHLORIDE tablets securely and dispose of properly [see Patient Counseling Information (17) ] .


More pills like ROUND R P 30

Related Pills

Oxycodone Hydrochloride 15 MG Oral Tablet

Rhodes Pharmaceuticals L.P.

oxycodone hydrochloride tablet

rhodes pharmaceuticals l.p.

oxycodone hydrochloride tablet

rhodes pharmaceuticals l.p.

oxycodone hydrochloride tablet

rhodes pharmaceuticals l.p.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site